pengxiang zhu

Dr. pengxiang zhu

Department of Functional Histology, Ehime University Graduate School of Medicine, Ehime 791-0295, Japan
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2002 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
TWTong‐Chun Wen
Tong‐Chun Wen
YSYasutaka Sadamoto
Yasutaka Sadamoto
JTJunya Tanaka
Junya Tanaka
PZpengxiang zhu
pengxiang zhu
KNKimihiko Nakata
Kimihiko Nakata
MSMasahiro Sakanaka
Masahiro Sakanaka

6 August 2008 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
PZpengxiang zhu
pengxiang zhu
RHRyuji Hata
Ryuji Hata
FCFang Cao
Fang Cao
FGFeng Gu
Feng Gu
YHYasushi Hanakawa
Yasushi Hanakawa
MSMasahiro Sakanaka
Masahiro Sakanaka
The differentiation and proliferation of neural stem cells (NSCs) are regulated by a combination of their intrinsic properties ( e.g ., transcription factors, epigenetic factors, and microRNA regulation) and cell‐extrinsic properties from the microenvironment around NSC ( e.g ., cytokines, growth factors, and cell‐cell contact). Recently, there has been a great interest in clarifying the mechanism of the influence of the microenvironment on NSCs, especially cell‐cell contact between NSCs and other types of cells nearby. In this study, we investigated whether microglial (Mi) cells influence the fate of NSCs. Coculture study showed that ramified Mi cells promoted astrogliogenesis and maintenance of NSCs through their paracrine effects. This microglia‐induced astrogliogenesis was inhibited by AG490 and by overexpression of the dominant‐negative form of Stat3 and SOCS3. Promoter assay revealed transactivation of Stat3 function in NSCs by Mi cells. Gene expression study revealed that mRNA of Notch family members (notchl‐3) and sox9 in NSCs was significantly upregulated by Mi cells, and this up‐regulation was inhibited by AG490. These results demonstrated that ramified Mi cells promoted astrogliogenesis and maintenance of NSCs by activating Stat3 function and via notch and sox9 signaling pathways.— Zhu, P., Hata, R., Cao, F., Gu, F., Hanakawa, Y., Hashimoto, K., Sakanaka, M. Ramified microglial cells promote astrogliogenesis and maintenance of neural stem cells through activation of Stat3 function. FASEB J. 22, 3866–3877 (2008)

27 June 2012 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
PZpengxiang zhu
pengxiang zhu
RHRyuji Hata
Ryuji Hata
MOMasahito Ogasawara
Masahito Ogasawara
FCFang Cao
Fang Cao
KKKenji Kameda
Kenji Kameda
MSMasahiro Sakanaka
Masahiro Sakanaka
The organic cation transporters OCT1, 2, and 3 (SLC22A1-3) have been implicated in the elimination of biogenic amines such as histamine. Among them, OCT3 was identified as an uptake-2 transporter, responsible for clearance of histamine. Because increasing evidence suggests the involvement of histamine in cerebral ischemia, we investigated the effects of targeted disruption of organic cation transporter-3 (Oct3) on the severity of ischemic brain damage. Transient focal ischemia for 1 hour was induced by occlusion of the middle cerebral artery (MCA) of homozygous Oct3-deficient mice and their wild-type (Wt) littermates. Although targeted disruption of Oct3 did not affect physiological parameters after MCA occlusion, this disruption significantly increased histamine content in the ischemic cortex and significantly reduced the infarct volume after cerebral ischemia. Furthermore, targeted disruption of Oct3 prevented the reduction of regulatory T-cell proportion after cerebral ischemia while this disruption did not affect Th1 and Th2 cells proportions after ischemia. Since repeated administration of L-histidine (a precursor of histamine) to Wt mice also showed the same effects, our observations suggested that OCT3 is the molecule responsible for clearance of ischemia-induced histamine in the brain and targeted disruption of Oct3 ameliorated ischemic brain damage through an increase in regulatory T cells.

22 September 2010 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
ATAkihiko Taguchi
Akihiko Taguchi
PZpengxiang zhu
pengxiang zhu
FCFang Cao
Fang Cao
AKAkie Kikuchi-Taura
Akie Kikuchi-Taura
YKYukiko Kasahara
Yukiko Kasahara
RHRyuji Hata
Ryuji Hata
Circulating bone marrow-derived immature cells, including endothelial progenitor cells, have been implicated in homeostasis of the microvasculature. Decreased levels of circulating endothelial progenitor cells, associated with aging and/or cardiovascular risk factors, correlate with poor clinical outcomes in a range of cardiovascular diseases. Herein, we transplanted bone marrow cells from young stroke-prone spontaneously hypertensive rats (SHR-SP) into aged SHR-SP, the latter not exposed to radiation or chemotherapy. Analysis of recipient peripheral blood 28 days after transplantation revealed that 5% of circulating blood cells were of donor origin. Cerebral infarction was induced on day 30 posttransplantation. Animals transplanted with bone marrow from young SHR-SP displayed an increase in density of the microvasculature in the periinfarction zone, reduced ischemic brain damage and improved neurologic function. In vitro analysis revealed enhanced activation of endothelial nitric oxide synthase and reduced activation p38 microtubule-associated protein (MAP) kinase, the latter associated with endothelial apoptosis, in cultures exposed to bone marrow-derived mononuclear cells from young animals versus cells from aged counterparts. Our findings indicate that partial rejuvenation of bone marrow from aged rats with cells from young animals enhances the response to ischemic injury, potentially at the level of endothelial/vascular activation, providing insight into a novel approach ameliorate chronic vascular diseases.

1 May 2009 in Brain Research
Verified
Journal Article
Closed access
FCFang Cao
Fang Cao
RHRyuji Hata
Ryuji Hata
PZpengxiang zhu
pengxiang zhu
MNMichinobu Niinobe
Michinobu Niinobe
MSMasahiro Sakanaka
Masahiro Sakanaka

1 January 2017 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
PZpengxiang zhu
pengxiang zhu
KSKeiichi Samukawa
Keiichi Samukawa
HFHiroko Fujita
Hiroko Fujita
HKHidemasa Kato
Hidemasa Kato
MSMasahiro Sakanaka
Masahiro Sakanaka
Red ginseng and its active ingredients have been shown to decrease neuron death after brain ischemia in experimental animals. However, little is known about the effects of orally administered ginseng extract on spinal cord injury. We orally gave red ginseng extract (RGE) to rats with compressed spinal cord injury (SCI). Open‐field locomotor scores were measured as indices of motor function. Histopathological changes and cytokine expressions in situ after SCI were evaluated. Compared to vehicle treatment, RGE treatment (350 mg/kg/day) significantly improved locomotor score up to levels close to those pre‐SCI, prevented neuron loss, and facilitated the restoration of white matter in the spinal cord at 14 days after SCI. Treatment with RGE caused less aggregation of Iba‐1‐positive microglia in grey and white matter at 7 days after SCI, upregulated the expression levels of VEGF and Bcl‐xL, and reduced IL‐1β and TNFα expressions in the spinal cord at 7 and 14 days after SCI. We concluded that oral administration of RGE facilitates almost complete functional recovery from motor and behavioral abnormalities in rats with SCI and prevents neuron death in situ, possibly through inhibition of inflammation and upregulation of neuroprotective factors in the injured spinal cord.